Eluxadoline - search results

United States - English - NLM (National Library of Medicine)

viberzi- eluxadoline tablet, film coated

allergan, inc. - eluxadoline (unii: 45tpj4mbq1) (eluxadoline - unii:45tpj4mbq1) - eluxadoline 75 mg - viberzi is indicated in adults for the treatment of irritable bowel syndrome with diarrhea (ibs-d). viberzi is contraindicated in patients: - without a gallbladder. these patients are at increased risk of developing serious adverse reactions of pancreatitis and/or sphincter of oddi spasm [see warnings and precautions ( 5.1, 5.2)] - with known or suspected biliary duct obstruction; or sphincter of oddi disease or dysfunction. these patients are at increased risk for sphincter of oddi spasm [see warnings and precautions ( 5.1)]. - with alcoholism, alcohol abuse or alcohol addiction, or in patients who drink more than 3 alcoholic beverages per day. these patients are at increased risk for acute pancreatitis [see warnings and precautions ( 5.1)] . - with a history of pancreatitis; or structural diseases of the pancreas, including known or suspected pancreatic duct obstruction. these patients are at increased risk for acute pancreatitis [see warnings and precautions ( 5.1)] . - with a known hypersensitivity r

European Union - English - EMA (European Medicines Agency)

truberzi

allergan pharmaceuticals international limited - eluxadoline - irritable bowel syndrome; diarrhea - antidiarrheals, intestinal antiinflammatory / antiinfective agents - truberzi is indicated in adults for the treatment of irritable bowel syndrome with diarrhoea (ibs d).